Medical gynecological gel and preparation method thereof
By preparing medical gynecological gels containing hydroxyethyl cellulose, glycerol, Centella asiatica extract and biological protein, the treatment problems of recurrence of fungal vaginitis and HPV infection are solved, and effective healing and antibacterialization of vaginal mucosa is achieved. Effect.
Patent Information
- Application Number
- CN202410926043.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art is difficult to effectively prevent and treat the recurrence of fungal vaginitis and the treatment of human papillomavirus (HPV) infection and related symptoms.
A medical gynecological gel preparation method, including hydroxyethyl cellulose, glycerol, Centella asiatica extract and biological protein, is used to prepare transparent hydrocoagulant with antiviral and healing effects through stirring and heating. glue.
It significantly improves the antibacterial and therapeutic effects of fungal vaginitis and HPV, promotes the healing and repair of the vaginal mucosa, and improves vaginal health.
Smart Images

Figure SMS_1 
Figure SMS_2
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of auxiliary therapeutic drugs for gynecological diseases, and in particular to a medical gynecological gel and a preparation method thereof. Background Art
[0002] Vaginitis is one of the most common gynecological diseases. It is an inflammatory disease caused by inflammatory changes in the vaginal mucosa and submucosal connective tissue caused by pathogenic microorganisms. However, candidal vaginitis is a common type of vaginitis and is common in clinical practice. Its main pathogen is Candida albicans. If it is not treated in time, it is easy to cause inflammation to invade the internal reproductive organs, affecting the patient's physical and mental health. The incidence of candidal vaginitis is as high as 75%, which is mainly divided into two categories: simple and complex. Among them, recurrent candidal vaginitis is symptomatic four or more times in a year, with an incidence of about 5%. How to prevent the recurrence of candidal vaginitis is a difficult problem in the treatment of gynecological vaginitis.
[0003] Human papillomavirus (HPV) is a genus of papillomavirus A belonging to the family Papovaviridae. It is a spherical DNA virus that can cause squamous epithelial proliferation in the skin and mucous membranes of the human body. Symptoms include common warts and genital warts (condyloma acuminatum). This virus is the beginning of genital cancer and cervical precancerous cell virus. Currently, preventive vaccines can effectively prevent HPV infection, but they have no obvious therapeutic effect on patients with HPV infection or precancerous lesions.
[0004] In summary, gynecological diseases are common diseases faced by women, which seriously affect women's physical health. However, the key to gynecological diseases lies in daily prevention and maintenance. Therefore, it is necessary to provide a product that is convenient for patients to use in daily life to prevent or assist in the treatment of gynecological diseases. Summary of the invention
[0005] The object of the present invention is to provide a medical gynecological gel and a preparation method thereof to solve the problems raised in the above background technology.
[0006] To achieve the above object, the present invention provides the following technical solution: a method for preparing a medical gynecological gel, which specifically comprises the following steps:
[0007] S1. Add purified water into a stirring tank, then add hydroxyethyl cellulose, and stir to obtain a hydroxyethyl cellulose solution;
[0008] S2, adding glycerol to the hydroxyethyl cellulose solution of step S1 to obtain a mixed solution 1;
[0009] S3, adding purified water to dilute the mixed solution 1 of step S2, and heating the mixed solution 1 at room temperature to 70-80° C., stirring and swelling to obtain a gel matrix;
[0010] S4, adding the Centella asiatica extract and the alkaline neutralizer to the gel matrix of step S3 to obtain a transparent hydrogel;
[0011] S5, adding purified water to the liquid preparation tank, and then adding biological protein and mixing and stirring to obtain a mixed solution II;
[0012] S6, stirring and mixing the transparent hydrogel and the mixed solution 2 to prepare the medical gynecological gel;
[0013] The raw materials of the medical gynecological gel are as follows: 8-10 parts of hydroxyethyl cellulose, 50-70 parts of glycerol, 10 parts of Centella asiatica extract, 2 parts of biological protein, 0.3 parts of alkaline neutralizer and 920-940 parts of purified water.
[0014] Preferably, the alkaline neutralizing agent is sodium hydroxide.
[0015] Preferably, the raw materials for preparing the medical gynecological gel include: 8 parts of hydroxyethyl cellulose, 70 parts of glycerol, 10 parts of Centella asiatica extract, 2 parts of biological protein, 0.3 parts of sodium hydroxide and 920 parts of purified water.
[0016] Preferably, the mass fraction of hydroxyethyl cellulose in the hydroxyethyl cellulose solution is 7.4-9.1%, the mass fraction of hydroxyethyl cellulose in the mixed solution 1 after dilution is 0.9-1.1%, and the mass fraction of biological protein in the mixed solution 2 is 2.0%.
[0017] Preferably, in step S2, the rotation speed of the stirring tank is 2000 r / min, and the stirring and mixing is performed for 10-20 min.
[0018] Preferably, the swelling time in step S3 is 10 to 15 hours.
[0019] Preferably, the pH value of the transparent hydrogel in step S4 is 5.0-7.0.
[0020] The invention also discloses a medical gynecological gel, which is prepared by adopting the preparation method of the medical gynecological gel.
[0021] Beneficial effects of the present invention:
[0022] The invention contains biological protein which can promote the healing of wound surface, induce the erosive tissue cells to produce endogenous interferon, regulate immunity, resist virus, promote healing and reduce inflammation, and is effectively applied to the treatment of gynecological diseases. The invention also contains Centella asiatica extract which can promote the formation of collagen in the dermis, regenerate fibrin, and help the damaged tissue to heal, and can not only promote the close connection between the epidermis and the dermis, but also inhibit the increase of fat cells, and has the effects of promoting healing and reducing inflammation. Through the synergistic effect of the biological protein and the Centella asiatica extract, the antibacterial effect of the gynecological gel on bacteria and human papillomavirus type 16 pseudovirus is improved, and the treatment or prevention effect of vaginitis is significantly improved. DETAILED DESCRIPTION
[0023] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0024] Embodiment 1:
[0025] An embodiment of the medical gynecological gel prepared by the present invention, the raw materials for preparing the medical gynecological gel in this embodiment are weighed as follows: 8g of hydroxyethyl cellulose, 2g of biological protein, 0.3g of sodium hydroxide, 70ml of glycerol, 10ml of Centella asiatica extract, and 920ml of purified water;
[0026] Preparation: S1. First, add 100 ml of purified water into a stirring tank, then add 8 g of hydroxyethyl cellulose, and stir to obtain a hydroxyethyl cellulose solution;
[0027] S2, adding 70 ml of glycerol to the hydroxyethyl cellulose solution of step S1 to obtain a mixed solution 1;
[0028] S3, adding 720 ml of purified water to dilute the mixed solution 1 of step S2, and heating the mixed solution 1 at room temperature to 80° C. and maintaining the temperature until the preparation is completed, stirring and swelling for 10 hours to obtain a gel matrix;
[0029] S4, adding 10 ml of Centella asiatica extract and 0.3 g of sodium hydroxide to the gel matrix of step S3 to obtain a transparent hydrogel with a pH value of 5.2;
[0030] S5. Add 100 ml of purified water into the liquid preparation tank, and then add 2 g of biological protein and mix and stir to obtain a mixed solution 2;
[0031] S6, stirring and mixing the mixed solution 2 and the transparent hydrogel to prepare the medical gynecological gel;
[0032] Filling: filling the medical gynecological gel obtained in the above step S6 into a disposable injector using a filling machine;
[0033] Packaging and warehousing: Use a labeling machine to label the disposable syringes after packaging, and then put the labeled products into storage.
[0034] Embodiment 2:
[0035] An embodiment of the medical gynecological gel prepared by the present invention, the raw materials for preparing the medical gynecological gel in this embodiment are weighed as follows: 9g hydroxyethyl cellulose, 2g biological protein, 0.3g sodium hydroxide, 70ml glycerol, 10ml Centella asiatica extract, 920ml purified water;
[0036] The preparation method of the medical gynecological gel in this embodiment is the same as that in Example 1.
[0037] Embodiment 3:
[0038] An embodiment of the medical gynecological gel prepared by the present invention, the raw materials for preparing the medical gynecological gel in this embodiment are weighed as follows: 10g hydroxyethyl cellulose, 2g biological protein, 0.3g sodium hydroxide, 70ml glycerol, 10ml Centella asiatica extract, 920ml purified water;
[0039] The preparation method of the medical gynecological gel in this embodiment is the same as that in Example 1.
[0040] Embodiment 4:
[0041] An embodiment of the medical gynecological gel prepared by the present invention, the raw materials for preparing the medical gynecological gel in this embodiment are weighed as follows: 9g hydroxyethyl cellulose, 2g biological protein, 0.3g sodium hydroxide, 50ml glycerol, 10ml Centella asiatica extract, and 940ml purified water;
[0042] The preparation method of the medical gynecological gel in this embodiment is the same as that in Example 1.
[0043] Comparative Example 1:
[0044] A comparative example of the medical gynecological gel of the present invention, the difference between this comparative example and Example 2 is that glycerin is not used and 990 parts of purified water are used.
[0045] Preparation: S1. First, add 100 ml of purified water into a stirring tank, then add 9 g of hydroxyethyl cellulose, and stir to obtain a hydroxyethyl cellulose solution;
[0046] S2, adding 790 ml of purified water to dilute the hydroxyethyl cellulose solution in step S1, and heating the mixed solution at room temperature to 80° C. and maintaining the temperature until the preparation is completed, stirring and swelling for 12 hours to obtain a gel matrix;
[0047] S3, adding 10 ml of Centella asiatica extract and 0.3 g of alkaline neutralizer to the gel matrix of step S2 to obtain a transparent hydrogel with a pH value of 5.1;
[0048] S4, add 100 ml of purified water into the liquid preparation tank, and then add 2 g of biological protein and mix and stir to obtain a mixed solution 2;
[0049] S5, stirring and mixing the mixed solution 2 and the transparent hydrogel to prepare the medical gynecological gel;
[0050] Filling: filling the medical gynecological gel obtained in the above step S5 into a disposable injector using a filling machine;
[0051] Packaging and warehousing: Use a labeling machine to label the disposable syringes after packaging, and then put the labeled products into storage.
[0052] Comparative Example 2:
[0053] A comparative example of the medical gynecological gel of the present invention is different from Example 2 only in that no Centella asiatica extract is used and 930 parts of purified water are used. The sources of the other components and the preparation method of the gynecological gel are the same as those of Example 2.
[0054] Comparative Example 3:
[0055] A comparative example of the medical gynecological gel of the present invention is different from Example 2 only in that biological protein is not used in the preparation.
[0056] Preparation: S1. First, add 100 ml of purified water into a stirring tank, then add 9 g of hydroxyethyl cellulose, and stir to obtain a hydroxyethyl cellulose solution;
[0057] S2, adding 70 ml of glycerol to the hydroxyethyl cellulose solution of step S1 to obtain a mixed solution 1;
[0058] S3, adding 720 ml of purified water to dilute the mixed solution 1 of step S2, and heating the mixed solution 1 at room temperature to 80° C. and maintaining the temperature until the preparation is completed, stirring and swelling for 12 hours to obtain a gel matrix;
[0059] S4, adding 10 ml of Centella asiatica extract and 0.3 g of sodium hydroxide to the gel matrix of step S3 to obtain a transparent hydrogel with a pH value of 5.2;
[0060] S5, adding 100 ml of purified water to dilute the transparent hydrogel in step S4 to prepare the medical gynecological gel;
[0061] Filling: filling the medical gynecological gel obtained in the above step S5 into a disposable injector using a filling machine;
[0062] Packaging and warehousing: Use a labeling machine to label the disposable syringes after packaging, and then put the labeled products into storage.
[0063] Test example:
[0064] 1. In vitro antibacterial test
[0065] The finished product solutions of Examples 1 to 4 and Comparative Examples 1 to 3 were taken for antibacterial tests on Candida albicans, Staphylococcus aureus and other pathogens according to GB 15979-2002 "Hygiene Standards for Disposable Hygiene Products", and the antibacterial rates were calculated.
[0066] The test results are shown in the table below:
[0067] Table 1 Antibacterial test results
[0068] Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3 Action time 5min 5min 5min 5min 5min 5min 5min Antibacterial rate (%) 99.97% 99.95% 99.96% 99.91% 99.95% 99.54% 0%
[0069] It can be seen from Example 2 and Comparative Example 3 that when no biological protein is added, the product has no bactericidal effect, which indicates that the biological protein has an excellent bactericidal effect.
[0070] It can be seen from the bactericidal rates of Example 2 and Comparative Example 2 that the Centella asiatica extract has the function of promoting the antibacterial effect.
[0071] 2. Animal experiments
[0072] Seven groups of bacteria-injected mice, totaling 21 mice, were prepared for drug administration experiments. The gels prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were respectively placed into the vaginas of bacteria-injected mice. Antibacterial experiments were conducted with three mice in each group. The results are shown in Table 2 below.
[0073] Table 2
[0074]
[0075] The experimental results are shown in Table 2. It can be seen from Table 2 that the gynecological gels prepared in Examples 1 to 4 can effectively inhibit the activity of pathogenic bacteria. By comparing the results of Example 2 with Comparative Example 2 and Comparative Example 3, it can be seen that the biological protein and Centella asiatica extract have a synergistic effect in inhibiting bacteria, which can significantly improve the therapeutic effect of vaginitis.
[0076] 3. Clinical trials
[0077] 1) Prepare 7 groups of 21 mice with vaginal mucosal injury for drug administration experiments; place the prepared gel into the vagina of the experimental mice to observe the integrity of the mucosal tissue, and conduct vaginal mucosal tissue repair experiments with 3 mice in each group;
[0078] 2) Conducting effect testing experiments on the repair test of human papillomavirus type 16 pseudovirus (HPV16) virus infection;
[0079] The results are shown in Table 3 below.
[0080] Table 3
[0081]
[0082] It can be seen from Examples 1 to 3 that as the content of hydroxyethyl cellulose increases, the repair effect of the vaginal mucosa decreases, and the killing rate of human papillomavirus type 16 pseudovirus (HPV16) is not affected, and when the content of hydroxyethyl cellulose is 8 parts, the repair effect reaches 99.10%. Therefore, Example 1 is the optimal mass ratio of each raw material of the present invention. By comparing Example 2 with Example 4 and Comparative Example 1, it can be seen that the use of glycerol to improve the lubricity of the gynecological gel has a promoting effect on the repair effect of the vaginal mucosa and the killing effect of human papillomavirus type 16 pseudovirus (HPV16). By comparing Example 2 with Comparative Example 2 and Comparative Example 3, it can be seen that the biological protein and Centella asiatica extract have a synergistic effect on the killing effect of human papillomavirus type 16 pseudovirus (HPV16).
[0083] Conclusion: For patients with symptoms of vaginitis, cervicitis and cervical erosion, the medical gynecological gel of the present invention can be applied to the vaginal wall to form a gel film, thereby promoting the healing of wounds such as cervical erosion; it can be used for the treatment and care of bacterial vaginitis, candidal vaginitis, fungal vaginitis and grade I and II cervical erosion; it can improve the symptoms of vaginal atrophy and vaginal dryness and increase vaginal elasticity.
[0084] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a medical gynecological gel, characterized in that: The specific steps include: S1. Add purified water into a stirring tank, then add hydroxyethyl cellulose, and stir to obtain a hydroxyethyl cellulose solution; S2, adding glycerol to the hydroxyethyl cellulose solution of step S1 to obtain a mixed solution 1; S3, adding purified water to dilute the mixed solution 1 of step S2, and heating the mixed solution 1 at room temperature to 70-80° C., stirring and swelling to obtain a gel matrix; S4, adding the Centella asiatica extract and the alkaline neutralizer to the gel matrix of step S3 to obtain a transparent hydrogel; S5, adding purified water to the liquid preparation tank, and then adding biological protein and mixing and stirring to obtain a mixed solution II; S6, stirring and mixing the transparent hydrogel and the mixed solution 2 to prepare the medical gynecological gel; The raw materials of the medical gynecological gel are as follows: 8-10 parts of hydroxyethyl cellulose, 50-70 parts of glycerol, 10 parts of Centella asiatica extract, 2 parts of biological protein, 0.3 parts of alkaline neutralizer and 920-940 parts of purified water.
2. The method for preparing a medical gynecological gel according to claim 1, characterized in that: The alkaline neutralizing agent is sodium hydroxide.
3. The method for preparing a medical gynecological gel according to claim 1, characterized in that: The preparation of the medical gynecological gel includes the following raw materials in parts by weight: 8 parts of hydroxyethyl cellulose, 70 parts of glycerol, 10 parts of Centella asiatica extract, 2 parts of biological protein, 0.3 parts of sodium hydroxide and 920 parts of purified water.
4. The method for preparing a medical gynecological gel according to claim 1, characterized in that: The mass fraction of hydroxyethyl cellulose in the hydroxyethyl cellulose solution is 7.4-9.1%, the mass fraction of hydroxyethyl cellulose in the mixed solution 1 after dilution is 0.9-1.1%, and the mass fraction of biological protein in the mixed solution 2 is 2.0%.
5. The method for preparing a medical gynecological gel according to claim 1, characterized in that: In step S2, the rotation speed of the stirring tank is 2000 r / min, and the stirring and mixing is performed for 10-20 minutes.
6. The method for preparing a medical gynecological gel according to claim 1, characterized in that: The swelling and mixing time in step S3 is 10 to 15 hours.
7. The method for preparing a medical gynecological gel according to claim 1, characterized in that: The pH value of the transparent hydrogel in S4 is 5.0-7.
0.
8. A medical gynecological gel, characterized in that: The medical gynecological gel is prepared by the preparation method of any one of claims 1 to 7.
